rs727505359
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_194323.3(OTOF):βc.3624delβ(p.Leu1209CysfsTer89) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,614,064 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: π 0.000020 ( 0 hom., cov: 33)
Exomes π: 0.0000096 ( 0 hom. )
Consequence
OTOF
NM_194323.3 frameshift
NM_194323.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.419
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0187 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-26458108-GC-G is Pathogenic according to our data. Variant chr2-26458108-GC-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 180120.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOF | NM_194323.3 | c.3624del | p.Leu1209CysfsTer89 | frameshift_variant | 29/29 | ENST00000339598.8 | NP_919304.1 | |
OTOF | NM_194248.3 | c.*129del | 3_prime_UTR_variant | 47/47 | ENST00000272371.7 | NP_919224.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOF | ENST00000339598.8 | c.3624del | p.Leu1209CysfsTer89 | frameshift_variant | 29/29 | 1 | NM_194323.3 | ENSP00000344521 | ||
OTOF | ENST00000272371.7 | c.*129del | 3_prime_UTR_variant | 47/47 | 1 | NM_194248.3 | ENSP00000272371 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251290Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135838
GnomAD3 exomes
AF:
AC:
2
AN:
251290
Hom.:
AF XY:
AC XY:
1
AN XY:
135838
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461864Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727232
GnomAD4 exome
AF:
AC:
14
AN:
1461864
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
727232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74360
GnomAD4 genome
AF:
AC:
3
AN:
152200
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2023 | Frameshift variant predicted to result in protein truncation as the last 22 amino acids are replaced with 88 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19250381, 12525542, 16371502, 14635104, 10903124, 26969326) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 21, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 180120). This frameshift has been observed in individual(s) with autosomal recessive deafness (PMID: 26969326; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs727505359, gnomAD 0.002%). This sequence change results in a frameshift in the OTOF gene (p.Leu1209Cysfs*89). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 22 amino acid(s) of the OTOF protein and extend the protein by 66 additional amino acid residues. The OTOF gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_194323.2, and corresponds to NM_194248.2:c.*129del in the primary transcript. - |
Nonsyndromic genetic hearing loss Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 28, 2021 | Variant summary: OTOF c.*129delG (NM_194248.2) is located in the untranslated mRNA region downstream of the termination codon. However, this variant may result in a frameshift in an alternative transcript (c.3624delG/p.Leu1209CysfsX89 in NM_194323). This transcript is cited as clinically relevant (Ensembl database). The variant allele was found at a frequency of 8e-06 in 251290 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.*129delG has been reported in the literature in at least one individual affected with Nonsyndromic Hearing Loss And Deafness, Type 9 (Sloan-Heggen_2016). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Rare genetic deafness Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 01, 2014 | The p.Leu1209fs variant in OTOF has been previously identified by our laboratory in one individual with auditory neuropathy who also carried a second likely pat hogenic OTOF variant. The variant was absent in large population studies. This f rameshift variant is located in exon 47A (also referred to as exon 47 or exon 48 in the literature), which is present in alternate splice isoforms of the OTOF g ene, one of which is specific to the inner ear. The variant is predicted to alte r the protein?s amino acid sequence beginning at position 1209, disrupt the term ination signal, and result in the addition of 67 amino acids to the end of the p rotein. This alteration occurs within the last exon and is more likely to escape nonsense mediated decay (NMD) and result in an elongated protein. In summary, a lthough additional studies are required to fully establish its clinical signific ance, this variant is likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at